Whan In Pharm Co.,Ltd. (KRX:016580)

Market Cap	187.06B +4.8%
Revenue (ttm)	266.19B +3.1%
Net Income	15.94B -18.0%
EPS	956.82 -24.8%
Shares Out	18.48M
PE Ratio	10.58
Forward PE	8.82
Dividend	300.00 (2.96%)
Ex-Dividend Date	Dec 29, 2025

Volume	15,386
Open	10,120
Previous Close	10,120
Day's Range	10,120 - 10,340
52-Week Range	9,990 - 13,210
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 27, 2026

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 601
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 016580

Financial Performance

In 2025, Whan In Pharm's revenue was 255.21 billion, a decrease of -1.69% compared to the previous year's 259.60 billion. Earnings were 13.60 billion, a decrease of -41.85%.